Highlights
- •CHSS-impregnated catheters for femoral venous access reduced the risk of CRBSI.
- •CHSS-impregnated catheters for femoral venous access saved costs.
- •CHSS-impregnated catheters were not associated with allergic reactions.
Sixty-four patients with chlorhexidine-silver sulfadiazine-impregnated catheters had
a lower rate of catheter-related bloodstream infection and lower central venous catheter-related
costs per catheter day than 190 patients with a standard catheter.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The prevalence of nosocomial infection in Intensive Care Units in EuropeResults of the European Prevalence of Infection in Intensive Care (EPIC) Study.The EPIC International Advisory Committee.JAMA. 1995; 274: 639-644
- Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis.Crit Care Med. 2009; 37: 2283-2289
- Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.Lancet Infect Dis. 2011; 11: 30-38
- Cost of intensive care unit-acquired bloodstream infections.J Hosp Infect. 2006; 63: 124-132
- Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.JAMA. 1999; 281: 261-267
- The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.Health Technol Assess. 2008; 12: 1-154
- Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection.JAMA. 1999; 282: 554-560
- New choices for central venous catheters: potential financial implications.Chest. 2003; 124: 275-284
- Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality.JAMA. 1994; 271: 1598-1601
- Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit.Arch Surg. 2001; 136: 229-234
- A semiquantitative culture method for identifying intravenous catheter-related infection.N Engl J Med. 1977; 296: 1305-1309
- Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs.Am J Infect Control. 2014; 42: 321-324
- The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia.Clin Infect Dis. 2008; 47: 1171-1175
- Lower assistance costs using rifampicin-miconazole-impregnated catheters than standard catheters.Am J Infect Control. 2011; 39: 895-897
- Rifampicin-miconazole-impregnated catheters save cost in jugular venous sites with tracheostomy.Eur J Clin Microbiol Infect Dis. 2012; 31: 1833-1836
- Guidelines for the prevention of intravascular catheter-related infections.Clin Infect Dis. 2011; 52: e162-e193
- Central venous catheter-related infection in a prospective and observational study of 2595 catheters.Crit Care. 2005; 9: R631-R635
- Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter.Anesthesiology. 1997; 87: 1242-1244
- Severe anaphylactic reaction due to a chlorhexidine-impregnated central venous catheter.Anesthesiology. 1998; 89: 1296-1298
- Two episodes of life-threatening anaphylaxis in the same patient to a chlorhexidine-sulphadiazine-coated central venous catheter.Br J Anaesth. 2001; 87: 306-308
- Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg?.Br J Anaesth. 2009; 103: 614-615
- In vitro and in vivo efficacy of catheters impregnated with antiseptics or antibiotics: evaluation of the risk of bacterial resistance to the antimicrobials in the catheters.Infect Control Hosp Epidemiol. 2001; 22: 640-646
- In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices.J Antimicrob Chemother. 2001; 47: 589-598
Article Info
Footnotes
This study was supported in part by grant Nos. I3SNS-INT-11-063 and I3SNS-INT-12-087 from Instituto de Salud Carlos III , Madrid, Spain, and cofinanced by Fondo Europeo de Desarrollo Regional .
Conflicts of interest: None to report.
Identification
Copyright
© 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
